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Abstract 
Objective: The strive for perfection is prevalent in the fitness industry. This study aimed 
to explore the use of products to enhance performance alongside exposure to exercise 
addiction (EA), appearance anxiety and self-esteem in fitness settings. 
  
Method: An online survey was prepared and piloted before wider dissemination in 
fitness clubs via snowballing and selected mailing lists. A list of commonly used 
products, including Performance and Image Enhancing Drugs (PIEDs) was provided. 
Exercise addiction (Exercise Addiction Inventory; EAI), anxiety levels (Appearance 
Anxiety Inventory; AAI) and their self-esteem (Rosenberg’s Self-Esteem Scale; RSE) 
were also measured. 
  
Results: 377 questionnaires were completed. A significant number of participants 
declared the use products either to lose weight (16%) or to reach their fitness goals 
(41%). The Internet played a major role in both the supply of information and the 
provision of the enhancement products (33.7%) and side effects were reported 
(10.5%). Only a limited number of participants sought a medical opinion about taking 
products (5.1%). EAI scores were high (m=20.02±4.1), AAI (m=15.98±4.8) showed an 
intermediate level of anxiety, while self-esteem was low (RSE m=12.59±2.2). 
  
Conclusion: This pilot study identified the emergence of a new drug trend in fitness 
settings and showed a potential relationship to exercise addiction, anxiety disorders 
and low self-esteem. The Internet played a crucial role in disseminating often untested 
products, including PIEDs without medical supervision and unwanted side-effects 
were reported. More studies in the field are required in order to safeguard public health 
and inform policy making. 
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INTRODUCTION 
In a society that perpetuates the strive for perfection, both professional 
and recreational athletes are inclined to take a variety of products to 
boost their physical performance. The phenomenon, once limited to 
elite athletes, now permeates to lower level athletes as well as amateur 
sportspersons of all ages, rapidly becoming a public health issue 
(Mazzoni, Barroso, & Rabin, 2017). Although the use of nutritional 
supplements is well governed and researched in the professional sporting 
industry, there is a lack of regulation surrounding the products 
accessed by the public (Corazza and Urrestarazu 2017; Reuter & Pardo, 
2016; GAO, 2002). An increasing prevalence of “supplementation” has 
been recorded over time amongst those engaged with physical activities  
(Morrison, 2004). It has been estimated that athletes, including 
85% of elite track and field athletes, use dietary supplements as part 
of their training routine (Maughan, Depiesse, & Geyer, 2009). Although 
both the potential benefits and risks of the use of supplements such 
as proteins, caffeine, creatine, and steriods have been well documented 
(e.g., Maughan, King, & Lea, 2004), very little is known about the 
increasing consumption of counterfeit and previously untested 
Performance and Image Enhancing Drugs (PIEDs), which is a cause of 
rising concern (Corazza et al., 2013, Kamber & Mullis, 2010; Molinero 
and Marquez, 2009; 2014; Müller, 2010; Verroken, 2000). 
 
PIEDs is an umbrella terms that 
encompasses a variety of different products including: anabolic steroids, 
sexual enhancers, growth hormones, and other drugs that can alter the 
functions of the body to enhance muscle growth, reduce body fat and 
promote weight loss (Bates & McVeigh, 2016). Although these products 
have been in circulation for some years and have largely been associated 
with athletes and body builders (Bates & McVeigh, 2016; Evans‐Brown, 
McVeigh, Perkins, & Bellis, 2012; World Anti‐Doping Agency, 2016), 
their recent availability on the Internet has increased their diffusion 
amongst a wider range of users in society (Coomber et al., 2014). 
 
PIEDS are often advertised with misleading marketing strategies as “natural,” 
“healthier,” and 
“safer” alternatives to medicines and other drugs as seen for other 
Novel Psychoactive Substances (Corazza et al., 2013). PIEDs are frequently 
used without previous consultation with a clinician or sport 
nutritionist, resulting in a lack of understanding concerning the potential 
associated risks, including the presence of untested or illicit  
substances. For instance, it has been estimated that 26% to 42% of 
available PIEDs on the market may be counterfeits (Graham et al., 
2009; Thevis et al., 2008). 
 
Preoccupation with body image concerns may be symptomatic of 
body dysmorphic disorder (BDD), which has a similar underlying 
pathology to obsessive–compulsive disorder attributable to a significant 
level of anxiety regarding physical appearance (Altamura, Paluello, 
Mundo, Medda, & Mannu, 2001; Beucke et al., 2016). Although literature 
exists examining both BDD and muscle dysmorphia (Chung, 2001; 
Leone, Sedory, & Gray, 2005; Murray et al., 2012), few studies have 
investigated this more broadly in terms of potential precursors to clinical 
disorders, such as levels of anxiety and self‐esteem. In some cases, 
the presence of an exercise addiction and the use of PIEDs to improve 
body image could obscure the presence of BDD and other obsessive— 
compulsive spectrum disorders. Furthermore, the literature in general 
does not appear conclusive regarding the presence in these environments 
of a form of behavioural addiction, namely, exercise addiction. 
It is well documented that exercise is both physically and psychologically 
beneficial to health; however, exercise without limits may have a negative 
impact on wellbeing, propellingresearchers to agree that exercise could, 
in some cases, be harmful (Szabo, 1995, 1998, 2000) and become 
addictive(Griffiths, 1997) with potential similarity to other behavioural addictions 
(De Luca, Simonato, Mooney, Bersani, & Corazza, 2017). 
 
To explore this ever‐changing scenario, a cross‐sectional investigation 
on the use of supplements (including drugs associated with 
physical exercise) was conducted amongst people engaged in exercise 
in the United Kingdom. The specific objectives of this study were as 
follows: (a) to investigate the use of products (including PIEDs) to 
either lose weight, or achieve fitness goals and (b) to understand any 
potential correlation to exercise addiction, appearance anxiety, and 
self‐esteem. Although previous studies have focused mainly on the 
use of steroids (e.g., Evans, 1997; Korkia & Stimson, 1997), to our 
knowledge, this is the first attempt to explore a wider use of products 
in fitness settings, as well as explore the level of appearance anxiety, 
self‐esteem and exercise addiction amongst the selected sample. 
 
METHODS 
A questionnaire was designed and piloted amongst a selected sample of 
gym users before wider dissemination. The study known as “Keep Fit,” 
was made available online through Qualtrics.com, and data were stored 
in the platform stored on the server of University of Hertfordshire. 
Recruitment was supported via a dedicated project website (https:// 
humanenhancementdrugs.com). To develop the research sample, a 
snowballing technique was used. A request of participation was sent 
initially to fitness clubs in the Hertfordshire and London areas, 
explaining the purpose of the research to be carried out and redirecting 
potential participants to the “Keep Fit” website, which was available 
throughout the research period from April 2015 to January 2016. The 
clubs approached varied in terms of the type of members they attracted 
(e.g., membership price) and the range of activities in their programmes. 
Adverts were also placed on various social media platforms (shared in 
popular fitness groups/for and by personal trainers). 
 
Although the investigation was originally conceived to be available 
in different countries (Italy, Hungary, and the Netherlands) to allow 
cross‐cultural comparison, the sampling for this study was limited to 
the United Kingdom. The anonymous questionnaire items revolved 
around the following thematic areas: (a) demographic information 
(age, gender, occupation, and type of exercise/sport in the gym); 
(b) supply and use of products to enhance fitness performance; and 
(c) measurement of the level of exercise addiction, self‐esteem and 
appearance anxiety via the following scales respectively: Exercise 
Addiction Inventory (EAI) (Terry, Szabo, & Griffiths, 2004) Rosenberg's 
Self‐esteem Scale (RSE; Rosenberg, 1965), and Appearance Anxiety 
Inventory (AAI; Veale et al., 2014). 
 
To elicit an accurate response, the term “product” on the questionnaire 
was used, as opposed to “PIED,” “supplement,” “medicine” or 
others, to allow inclusion of a wide of substances available to this population. 
The selection of products was prepared in consultation with a 
network of informants, which included sport nutritionists, clinicians, 
and sample representatives, who also supported initial piloting of the 
questionnaire. This process enabled us to capture the current trends 
as well as inform a more targeted approach in future studies. The question 
on the consumption of products was framed with reference to their 
use: (a) to help with weight loss and (b) to help to reach fitness goals. 
 
Data were processed with SPSS v23 and made use of means and 
frequencies for the following: the description of the sample [age, gender, 
and occupation], types and levels of sport activities, use of products, 
the source of products, the reasons for product use; side effects of products; 
body mass index (BMI); and EAI, AAI, and RSE scale. The chisquared 
was used to assess differences according to gender regarding 
questions concerning product use, whereas ANOVA were used to evaluate 
possible gender differences between validated scales (EAI, AAI, and 
RSE). Due to the small sample size, it was not possible to meaningfully 
analyse the scales according to whether respondents took products. 
 
Each participant was formally asked to provide consent prior to 
completing the questionnaire. Responses were collected anonymously, 
and the study complied with the United Kingdom Data Protection Act 
1998. The study was approved by the Ethics Committee at the University 
of Hertfordshire prior to data collection (HSK/SF/UH/00104). All responses  
were anonymous and confidential, stored securely, and 
were made accessible only to members of the research team.  
 
RESULTS 
Overall, 377 participants (Table 1) fully completed the questionnaire, 
with an average age of 35 years old (m = 35.58 ± 13.49). The majority 
of the sample were employed, (n = 279; 74%), whereas only 16.9% 
were students and 4.5% retired at the time of data collection. The male 
BMI (m = 26.31 ± 3.8) was statistically different [F(1,351) = 27.77, 
p = .000] from the female result (m = 24.02 ± 4.3). As highlighted in 
Table 2, the chosen fitness activities varied according to gender; however, for the 
overall sample, 73.5% walked regularly, 62.3% lifted 
weights, 48.5% ran, and 48.0% engaged in body weight exercises. 
The main result of this study was that 26% of the respondents 
(n = 100) disclosed that they used products to lose weight, whereas 
41% of participants (n = 152) reported use of products to achieve their 
fitness goals (Table 1). The most commonly reported products used to 
lose weight were proteins (47%), caffeine (46%), and nitric oxide (17%). 
Use of illegal compounds to lose weight was also reported, most notably 
amphetamines (14%). Although the majority of those who reported 
product use were male, across all products, statistical analysis did not 
find differences between male and female of the sample in the use 
of products (Table 1). With regard to achieving fitness goals, significantly 
more males (X2 = 65.70, p = .000) (Table 1) used products. The 
most commonly reported products regardless of gender were protein 
(41%), caffeine (30%), nitric oxide (13%), and anabolic steroids (7%). 
Although the experience of side effects was not explored extensively 
in this pilot study, overall, 10.5% (n = 38) of the sample reported 
experiencing side effects most commonly acne, palpitations, change in 
mood, and gastro‐intestinal effects. Although significantly more men 
(X2 = 33.90, p = .000) reported side effects than women, this could 
be because more men reported product use overall. 
 
 
 
 
*multiple choice answers  
 
Appearance anxiety, self‐ esteem, and exercise addiction 
Keep Fit respondents self‐reported an average score on the AAI of 
17.33 (±5.6), with significantly higher scores reported amongst females 
[F(1,341) = 17.76, (p = .000)], which clearly indicate issues with appearance 
anxiety and low body satisfaction. Results also indicated that 
those who were using products to lose weight (n = 100) reported 
higher levels (m = 20.26 ± 4.91) of appearance anxiety compared to 
those who did not report product use with the aim of weight loss 
(n = 252, m = 16.28 ± 4.93). However, there was no difference 
reported in appearance anxiety between those who were and were 
not using products to help them achieve their fitness goals. Due to 
the limited sample size, no further data analysis was undertaken and 
this argument will need to be explored in future studies. 
The RSE shown a clear prevalence of low self‐esteem amongst 
those who used products for weight loss (m = 12.96 ± 2.17) and those 
who used products to reach fitness goals (m = 12.52 ± 2.14) with no 
gender differences (Table 1). On this scale, a score between 0 and 15 
out of 30 can be considered as demonstrating low self‐esteem (Rosenberg, 
1965). In terms of exercise addiction, as expected, respondents 
considered themselves “vulnerable to be addicted to exercise” 
(m = 19.37 ± 4.0) according to the EAI (Terry et al., 2004), with males 
being particularly at risk of exercise addiction in the overall group 
([F(1,358) = 8.08, p = .005] Table 1). Again, because of the limited sample 
size for this pilot study, it was not possible to establish a significant 
correlation between the use of products and either RSE or EAI. 
 
 
DISCUSSION 
The results of this pilot study demonstrated a high prevalence of product 
use to either lose weight (n = 100, 26%) or assist the achievement 
of fitness goals (n = 152, 41%) amongst the self‐selected sample. Such 
a result appears to be higher than reported in Italy (20%; Piacentino, 
Q6 2016) and Denmark (15%; Bojsen‐Møller & Christiansen, 2010). 
Although females were more inclined to use products to lose weight 
(n = 53, 53%), the majority of those who reported product use to 
achieve their fitness goals such as building muscular structure were 
male (n = 114, 75%). When pathological, such preoccupation with muscularity 
has also been defined as muscle dysmorphia or “bigorexia” 
(Pope, Gruber, Choi, Olivardia, & Phillips, 1997). The expression of 
muscularity in terms of improving physical appearance is not a new 
phenomenon in Western culture. Greek and Roman mythologies present 
numerous references to muscular gods, anticipating contemporary 
bodybuilder figures (Kanayama, Hudson, & Pope, 2012). However, 
although the attempt has always been that of aesthetic modification, 
modalities to achieve this goal over time have changed and the use 
of supplements, including PIEDs, to accentuate masculinity has now 
become a trend that warrants further attention. 
 
Overall, respondents reported the consumption of rather heterogeneous 
classes of compounds, including legal supplements (e.g., proteins 
and caffeine), medical drugs (e.g., anabolic steroids), and illicit 
compounds (e.g., amphetamine) to lose weight and to reach their goals 
in fitness. The Internet was of importance, with around a third of the 
sample citing the Internet as a main source of information and purchase 
for these compounds, regardless of gender and the reasons for 
engaging in product use. As previously highlighted (Corazza et al., 
2014), advances in science and technology, alongside the increasing 
popularity of the Internet, have made supplements and PIEDs more 
available to all socio‐economic classes. Influenced by a culture, which 
incites the pursuit of perfection, individuals use drugs as a “quick fix” 
to achieve unrealistic standards of beauty and strength. Females are 
particularly targeted (Bahrke & Yesalis, 2004). For instance, previous 
investigation in 2012 has shown that 70% of adult women in the 
United Kingdom, felt pressure from television and magazines to have 
a perfect body and confirm to unrealistic beauty ideals (All Party Parliamentary 
Group on Body Image, 2012). 
 
Although a limitation of this pilot study was that the experience of 
side effects was not reported in relation to the consumption of specific 
products, the variety of side effects reported requires further investigation. 
Of the side effects reported dermatological problems were frequently 
reported with acne being the most common, potentially due to 
the androgenic effect on the sebaceous glands secreting more oils. 
This was also reported in previous studies where acne was found prevalent 
in up to 50% of anabolic steroid abusers in a previous study 
(Melnik, Jansen, & Grabbe, 2007). Other side effects were reported 
in the gastrointestinal and cardiovascular areas. Compounding these 
adverse effects is the potential presence of polypharmacy amongst different 
PIEDs. It has been shown that there is a high correlation 
between the use of psychoactive drugs and PIEDs (Piacentino et al., 
2016; Pope et al., 2014; Sagoe et al., 2015), although Bates and 
McVeigh (2016) more recently found that only a minority of their sample 
of 663 participants using PIEDs reported the use of alcohol or 
other illicit substances to potentially harmful levels. Future research 
could further investigate respondents' physical health, in that physical 
limitations may prevent elements of exercise, which may have impact 
on an individual's decision to use products. Gastro‐intestinal disorders 
would also be a viable route of enquiry in this population, owing to the 
impact on diet, and consequently exercise. The presence of physical illness 
may also require medication, which could have severe implications 
regarding polypharmacy as described above. 
 
It is also worth considering that a proportion of the products used 
by our sample were purchased from potentially unregulated websites, 
which enhances the risk of contamination and/or the consumption of 
undisclosed ingredients (Corazza et al., 2013). The fact that supplements, 
including PIEDs, are widely available on the Internet presents 
a false reassurance about their safety. For instance, it is often unknown 
(Pillitteri et al., 2008) that the current licencing in place for food regulation 
allows the sale of products such as weight loss pills on the basis 
of the mere “presumption of safety” without any further form of 
approval concerning safety and efficacy before being sold to the public. 
This implies that the sold product is safe until proven otherwise (see 
GAO, 2002 for full details on the process). Only if a product is later 
found to be unsafe or dangerous, can it then be removed from the 
market and manufacturers can be prosecuted. There may be differences 
in the case of a product being contaminated with a psychoactive 
substance, as it might fall within the remit of the U.K. Psychoactive 
Substances Bill 2016 (Corazza & Roman‐Urrestarazu, 2017). 
 
Other previously unstudied elements emerged from our study. 
Issues relating to appearance anxiety and low body satisfaction were 
detected by the AAI. However, to confirm the validity of such a result, 
more targeted studies are needed with larger sample sizes. Such a tendency 
was also confirmed by the results that emerged from the RSE, 
which were undoubtedly low amongst the sample regardless of gender. 
Further investigations are also needed to better understand the 
connection between these aspects and the use of products, to enable 
the development of effective intervention. The EAI is considered a 
valid and reliable psychometric instrument (Terry et al., 2004) to identify 
exercise addiction. The level detected in this sample suggested that 
respondents (males in particular) should be considered at risk for this 
behavioural addiction and thus more exposed to injuries and 
other negative consequences in accordance with existing literature 
(e.g., De Luca et al., 2017). 
 
In conclusion, Keep Fit detected for the first time amongst a population 
in the U.K. fitness clubs, a risk of exercise addiction, appearance 
anxiety and low self‐esteem as well as an inclination to use products to 
supplement their physical exercise likely in the absence of medical consultation. 
It could be argued that current legislative frameworks provide 
an inadequate response to the proliferation of supplement 
products for fitness, such as PIEDs, and novel regulatory approaches 
are required to face such an emerging challenge (Corazza & Roman‐ 
Urrestarazu, 2015, 2017). Efforts to restrict false or misleading advertising 
should also be implemented. Vulnerable individuals might be 
further affected by the captivating marketing strategies used to sell 
these products online (e.g., via websites, social networking, and email 
alerts), reinforcing the ideals of attaining “perfection” more rapidly by 
using their products (Corazza et al., 2014). Claims such as “lose 10 kg 
in a week,” “lose two dress sizes in 14 days” should be carefully monitored 
by the authorities. Due to the high demand for these products, 
there is also a risk of these drugs being distributed through the fitness 
industry such as has been recently reported in Australia (Crime Corruption 
Commission, 2016). The limited knowledge about the supply and 
the content as well as the loose legislation on supplements makes this 
an area that deserves immediate attention not only by healthcare professionals 
but also regulatory theories to safeguard public health. 
 
LIMITATIONS 
As this was a pilot study, a very little explored area of research, authors 
are aware of its limitations as follows: (a) limited sample size and thus 
the analysis of some variables were not exhaustive: above all, a clear 
relationship between products use and psychopathological features 
of users was premature; (b) nonstratified population; (c) reliant on 
self‐reported use of PIEDs, not validated by biological testing; (d) a 
clearer terminology of PIEDs need to be established to better categorise 
the types of products used; (e) the length of the survey and nature 
of the questions being asked may have deterred participants from 
completing the survey; and (f) the lack of information on the frequency 
and duration of the exercise. 
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